Neuphoria Therapeutics Inc. (NEUP) Financials
NEUP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 28.7 million | 4.1 million |
| March 31, 2026 | 34.8 million | 5.4 million |
| Dec. 31, 2025 | 36.6 million | 6.9 million |
| Sept. 30, 2025 | 27.3 million | 14.8 million |
NEUP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -12.3 billion | 351.3 million |
| March 31, 2026 | -3.9 million | 70286 |
| Dec. 31, 2025 | -6.4 million | 93701 |
| Sept. 30, 2025 | -3.8 million | 111277 |
NEUP Net Income
No data available :(
NEUP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 19.9 million | - | - |
| March 31, 2026 | 19.4 million | - | - |
| Dec. 31, 2025 | 22.2 million | - | - |
| Sept. 30, 2025 | 13.6 million | - | 85210 |
NEUP Shares Outstanding
NEUP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 419783 | 1.2 million | - |
| March 31, 2026 | 2 | -752550 | 2.5 million | - |
| Dec. 31, 2025 | - | 1.0 million | 3.2 million | - |
| Sept. 30, 2025 | 2 | 5.7 million | 2.8 million | - |
NEUP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.2 million | 165683 |
| March 31, 2026 | - | 165695 |
| Dec. 31, 2025 | - | 165789 |
| Sept. 30, 2025 | - | 165792 |
NEUP
Price: $3.45
52 week price:
Earnings Per Share: -3.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 18.2 million